<DOC>
	<DOCNO>NCT01087632</DOCNO>
	<brief_summary>Metabolic syndrome highly prevalent condition characterize visceral obesity , abnormality glucidic lipid metabolism , increase risk cardiovascular event . Such finding appear associate decrease insulin sensitivity . Management metabolic syndrome currently aim treat individual component disease without address underlie pathophysiologic mechanism ; translate multidrug regimen , high cost patient compliance issue . Armolipid Plus ( association berberine 500 mg , red yeast rice title 3 mg monacolin K , policosanol 10 mg , coenzyme Q10 2 mg , astaxanthin 0,5 mg , folic acid 0,2 mg ) find effective reduce blood cholesterol triglyceride , improve endothelial function ; subgroup analyse also suggest benefit index insulin resistance . Aim study evaluate effect Armolipid Plus insulin sensitivity diagnostic parameter metabolic syndrome . 60 patient enrol randomized , double-blind , placebo-controlled trial ; active treatment consist Armolipid Plus ( 1 tbl qd ) . Primary end point reduction insulin/glucose ratio , overnight fast ( HOMA index ) oral glucose tolerance test ( OGTT ) .</brief_summary>
	<brief_title>Armolipid Plus Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Red yeast rice</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<mesh_term>Policosanol</mesh_term>
	<criteria>Male Female 1865 age , diagnosis metabolic syndrome , define presence waist circumference &gt; 102 cm ( M ) &gt; 88 cm ( F ) , two criterion : fasting blood glucose &gt; 100 mg ; systolic blood pressure &gt; 135 diastolic blood pressure &gt; 85 mmHg patient treatment antihypertensive drug ; triglyceridemia &gt; 150 mg/dl ; HDL cholesterolemia &lt; 40 mg/dl ( M ) , &lt; 50 mg/dl ( F ) . pregnancy diabetes mellitus pharmacologic treatment ; hepatic failure ; creatininemia &gt; 2 mg/dl ; triglyceridemia &gt; 500 mg/dl ; heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Metabolic Syndrome Insulin-resistance Endothelial Function</keyword>
</DOC>